PTP1B and TC-PTP: regulators of transformation and tumorigenesis

PTP1B and T cell PTP (TC-PTP) are protein tyrosine phosphatases (PTPs) that share high sequence and structural homology yet play distinct physiological roles. While PTP1B plays a central role in metabolism and is an attractive drug target for obesity and type 2 diabetes, TC-PTP is necessary for the control of inflammation. In this review, we will discuss the growing evidence for the involvement of PTP1B in cancer, while proposing a role for TC-PTP in inflammation-induced tumorigenesis. Given the challenge of developing inhibitors specific for PTP1B alone, it is necessary to consider both enzymes and their roles in various cancer models.

[1]  F. Gruber,et al.  Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth. , 2006, Cancer research.

[2]  J. Lilien,et al.  The Nonreceptor Protein Tyrosine Phosphatase PTP1B Binds to the Cytoplasmic Domain of N-Cadherin and Regulates the Cadherin–Actin Linkage , 1998, The Journal of cell biology.

[3]  Seiya Kato,et al.  IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice , 2006, The Journal of experimental medicine.

[4]  A. Elefanty,et al.  Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1 , 1999, Leukemia.

[5]  M. Tremblay,et al.  Protein Tyrosine Phosphatases: Emerging Regulators of Apoptosis , 2007, Cell cycle.

[6]  D. Hill,et al.  Direct Binding of the Proline-rich Region of Protein Tyrosine Phosphatase 1B to the Src Homology 3 Domain of p130Cas* , 1996, The Journal of Biological Chemistry.

[7]  Kenneth M. Yamada,et al.  Tyrosine phosphorylation of the CrkII adaptor protein modulates cell migration , 2003, Journal of Cell Science.

[8]  N. Tonks,et al.  Identification of YB‐1 as a regulator of PTP1B expression: implications for regulation of insulin and cytokine signaling , 2003, The EMBO journal.

[9]  M. Dobrovolskaia,et al.  Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership. , 2005, Current cancer drug targets.

[10]  N. Tonks,et al.  Association of the T-cell Protein Tyrosine Phosphatase with Nuclear Import Factor p97* , 1997, The Journal of Biological Chemistry.

[11]  R. Schreiber,et al.  Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice , 1998 .

[12]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[13]  T. Pellinen,et al.  Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP. , 2005, Nature cell biology.

[14]  F. Haj,et al.  Regulation of protein tyrosine phosphatase 1B by sumoylation , 2007, Nature Cell Biology.

[15]  B. Franza,et al.  Multi‐site phosphorylation of the protein tyrosine phosphatase, PTP1B: identification of cell cycle regulated and phorbol ester stimulated sites of phosphorylation. , 1993, The EMBO journal.

[16]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[17]  Yu-Rong Fu,et al.  Identification of a Nuclear Stat 1 Protein Tyrosine Phosphatase , 2002 .

[18]  B. Neel,et al.  Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. , 2007, Cancer research.

[19]  A. Darzi,et al.  The Risk of Cancer in Patients with Crohn’s Disease , 2007, Diseases of the colon and rectum.

[20]  K. Hirokawa,et al.  Expression of protein tyrosine phosphatases and its significance in esophageal cancer. , 2000, Experimental and molecular pathology.

[21]  P. Herrlich,et al.  UVA inactivates protein tyrosine phosphatases by calpain‐mediated degradation , 2004, EMBO reports.

[22]  M. Kizaki,et al.  STI571-resistant KT-1 cells are sensitive to interferon-alpha accompanied by the loss of T-cell protein tyrosine phosphatase and prolonged phosphorylation of Stat1. , 2003, Experimental hematology.

[23]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[24]  B. Kennedy,et al.  Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. , 2002, Developmental cell.

[25]  H. Kantarjian,et al.  Down-regulation of interleukin-3/granulocyte-macrophage colony-stimulating factor receptor beta-chain in BCR-ABL(+) human leukemic cells: association with loss of cytokine-mediated Stat-5 activation and protection from apoptosis after BCR-ABL inhibition. , 2001, Blood.

[26]  Young-Bum Kim,et al.  PTP1B regulates leptin signal transduction in vivo. , 2002, Developmental cell.

[27]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[28]  J. Lilien,et al.  Regulated binding of PTP1B-like phosphatase to N-cadherin: control of cadherin-mediated adhesion by dephosphorylation of beta-catenin , 1996, The Journal of cell biology.

[29]  L. Nanney,et al.  Altered distribution and expression of protein tyrosine phosphatases in normal human skin as compared to squamous cell carcinomas , 1997, Journal of cutaneous pathology.

[30]  D. Brautigan,et al.  Serine phosphorylation of protein tyrosine phosphatase (PTP1B) in HeLa cells in response to analogues of cAMP or diacylglycerol plus okadaic acid , 1993, Molecular and Cellular Biochemistry.

[31]  F. Haj,et al.  Regulation of Receptor Tyrosine Kinase Signaling by Protein Tyrosine Phosphatase-1B* , 2003, The Journal of Biological Chemistry.

[32]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[33]  R. Schreiber,et al.  Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  W. Muller,et al.  Signal transduction in mammary tumorigenesis: a transgenic perspective , 2000, Oncogene.

[35]  B. Kennedy,et al.  Attenuation of Adhesion-dependent Signaling and Cell Spreading in Transformed Fibroblasts Lacking Protein Tyrosine Phosphatase-1B , 2001, The Journal of Biological Chemistry.

[36]  M. Tremblay,et al.  Protein tyrosine phosphatase 1B negatively regulates macrophage development through CSF-1 signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Lilien,et al.  PTP1B Modulates the Association of β-Catenin with N-cadherin through Binding to an Adjacent and Partially Overlapping Target Site* , 2002, The Journal of Biological Chemistry.

[38]  E. Newell,et al.  T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. , 2004, Blood.

[39]  K. Black,et al.  A Peroxisome Proliferator-activated Receptor-γ Agonist, Troglitazone, Facilitates Caspase-8 and -9 Activities by Increasing the Enzymatic Activity of Protein-tyrosine Phosphatase-1B on Human Glioma Cells* , 2006, Journal of Biological Chemistry.

[40]  E. Krebs,et al.  Suppression of v-fms-induced transformation by overexpression of a truncated T-cell protein tyrosine phosphatase. , 1993, Oncogene.

[41]  E. Chevet,et al.  Protein-tyrosine Phosphatase 1B Potentiates IRE1 Signaling during Endoplasmic Reticulum Stress* , 2004, Journal of Biological Chemistry.

[42]  Richard Simon,et al.  Initiating oncogenic event determines gene-expression patterns of human breast cancer models , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Ben-Baruch.  Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. , 2006, Seminars in cancer biology.

[44]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[45]  Carlo Riccardo Rossi,et al.  Tumor necrosis factor, cancer and anticancer therapy. , 2005, Cytokine & growth factor reviews.

[46]  B. Dörken,et al.  Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression , 1997, Nature Medicine.

[47]  P. Sassone-Corsi,et al.  Activation of transcription via AP-1 or CREB regulatory sites is blocked by protein tyrosine phosphatases. , 1991, Oncogene.

[48]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[49]  Young-Bum Kim,et al.  Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice , 2000, Molecular and Cellular Biology.

[50]  C. McCulloch,et al.  Beyond the epithelium: Cadherin function in fibrous connective tissues , 2007, FEBS letters.

[51]  N. Tonks,et al.  Purification of the major protein-tyrosine-phosphatases of human placenta. , 1988, The Journal of biological chemistry.

[52]  J. Chernoff,et al.  Transformation Suppression by Protein Tyrosine Phosphatase 1B Requires a Functional SH3 Ligand , 1998, Molecular and Cellular Biology.

[53]  J. Frangioni,et al.  Calpain‐catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP‐1B) in human platelets. , 1993, The EMBO journal.

[54]  S. Weitzman,et al.  Chronic inflammation and cancer. , 2002, Oncology.

[55]  G. Lesinski,et al.  The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line. , 2004, The Journal of surgical research.

[56]  Nayoung Kim,et al.  Double Knockouts Reveal that Protein Tyrosine Phosphatase 1B Is a Physiological Target of Calpain-1 in Platelets , 2007, Molecular and Cellular Biology.

[57]  E. Asante-Appiah,et al.  Protein Tyrosine Phosphatase-1B Dephosphorylation of the Insulin Receptor Occurs in a Perinuclear Endosome Compartment in Human Embryonic Kidney 293 Cells* , 2004, Journal of Biological Chemistry.

[58]  D. Lawrence,et al.  The Role of Protein-tyrosine Phosphatase 1B in Integrin Signaling* , 2005, Journal of Biological Chemistry.

[59]  F. Liu,et al.  Protein tyrosine phosphatase 1B negatively regulates integrin signaling , 1998, Current Biology.

[60]  M. Tremblay,et al.  Substrate-trapping techniques in the identification of cellular PTP targets. , 2005, Methods.

[61]  M. Tremblay,et al.  Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development. , 2005, Cancer research.

[62]  J. Chernoff,et al.  Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor. , 1997, The Biochemical journal.

[63]  M. Smyth,et al.  Cytokines in cancer immunity and immunotherapy , 2004, Immunological reviews.

[64]  J. Bjorge,et al.  Identification of Protein-tyrosine Phosphatase 1B as the Major Tyrosine Phosphatase Activity Capable of Dephosphorylating and Activating c-Src in Several Human Breast Cancer Cell Lines* , 2000, The Journal of Biological Chemistry.

[65]  N. Aoki,et al.  A Cytosolic Protein-tyrosine Phosphatase PTP1B Specifically Dephosphorylates and Deactivates Prolactin-activated STAT5a and STAT5b* , 2000, The Journal of Biological Chemistry.

[66]  B. Kemp,et al.  The Protein-tyrosine Phosphatase TCPTP Regulates Epidermal Growth Factor Receptor-mediated and Phosphatidylinositol 3-Kinase-dependent Signaling* , 1999, The Journal of Biological Chemistry.

[67]  M. Tremblay,et al.  The role of protein tyrosine phosphatase 1B in Ras signaling , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[68]  A. Koong,et al.  The Unfolded Protein Response: A Novel Component of the Hypoxic Stress Response in Tumors , 2005, Molecular Cancer Research.

[69]  M. Tremblay,et al.  The T Cell Protein Tyrosine Phosphatase Is a Negative Regulator of Janus Family Kinases 1 and 3 , 2002, Current Biology.

[70]  E. Krebs,et al.  Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Lloyd J. Old,et al.  and shape tumour immunogenicity , 2001 .

[72]  A. Ullrich,et al.  Differential activities of protein tyrosine phosphatases in intact cells. , 1993, The Journal of biological chemistry.

[73]  A. Elefanty,et al.  Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[74]  A. Bosserhoff,et al.  Integrin signaling in malignant melanoma , 2005, Cancer and Metastasis Reviews.

[75]  J. Trapani,et al.  Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ , 2002, The Journal of experimental medicine.

[76]  M. Loh,et al.  SHP-2 and myeloid malignancies. , 2004, Current opinion in hematology.

[77]  B. Franza,et al.  Protein Tyrosine Phosphatase 1B Antagonizes Signalling by Oncoprotein Tyrosine Kinase p210 bcr-abl In Vivo , 1998, Molecular and Cellular Biology.

[78]  C. Harris,et al.  Radical causes of cancer , 2003, Nature Reviews Cancer.

[79]  G. Feldman,et al.  Cells Previously Desensitized to Type 1 Interferons Display Different Mechanisms of Activation of Stat-dependent Gene Expression from Naïve Cells* , 2004, Journal of Biological Chemistry.

[80]  T. Onytiganis.  Development of ''substrate-trapping'' mutants to identify physiological substrates of protein tyrosine phosphatases , 1997 .

[81]  R. Bast,et al.  Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression. , 1994, Journal of the National Cancer Institute.

[82]  J. Dixon,et al.  Expression of a protein tyrosine phosphatase in normal and v-src- transformed mouse 3T3 fibroblasts , 1992, The Journal of cell biology.

[83]  W. Cavenee,et al.  The Protein Tyrosine Phosphatase TCPTP Suppresses the Tumorigenicity of Glioblastoma Cells Expressing a Mutant Epidermal Growth Factor Receptor* , 2001, The Journal of Biological Chemistry.

[84]  B. Kemp,et al.  Cellular Stress Regulates the Nucleocytoplasmic Distribution of the Protein-tyrosine Phosphatase TCPTP* , 2001, The Journal of Biological Chemistry.

[85]  P. Branton,et al.  Promoter analysis of the murine T-cell protein tyrosine phosphatase gene. , 1999, Gene.

[86]  John Wagner,et al.  Impaired Bone Marrow Microenvironment and Immune Function in T Cell Protein Tyrosine Phosphatase–deficient Mice , 1997, The Journal of experimental medicine.

[87]  Peter J Verveer,et al.  Imaging Sites of Receptor Dephosphorylation by PTP1B on the Surface of the Endoplasmic Reticulum , 2002, Science.

[88]  B. Neel,et al.  Phosphorylated α-Actinin and Protein-tyrosine Phosphatase 1B Coregulate the Disassembly of the Focal Adhesion Kinase·Src Complex and Promote Cell Migration* , 2006, Journal of Biological Chemistry.

[89]  M. Benito,et al.  Levels of protein tyrosine phosphatase 1B determine susceptibility to apoptosis in serum‐deprived hepatocytes , 2007, Journal of cellular physiology.

[90]  A. Mantovani,et al.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.

[91]  Paola Defilippi,et al.  p130Cas: a versatile scaffold in signaling networks. , 2006, Trends in cell biology.

[92]  M. Tremblay,et al.  TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-{gamma}. , 2007, Blood.

[93]  K. Black,et al.  A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells. , 2006, Journal of Biological Chemistry.

[94]  A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. , 2002, Molecular endocrinology.

[95]  J. Lilien,et al.  Impaired Integrin-mediated Adhesion and Signaling in Fibroblasts Expressing a Dominant-negative Mutant PTP1B , 1998, The Journal of cell biology.

[96]  T. Issad,et al.  Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells. , 2003, EMBO reports.

[97]  Tetsuya Yamamoto,et al.  The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. , 2002, Biochemical and biophysical research communications.

[98]  M. Mareel,et al.  Clinical, cellular, and molecular aspects of cancer invasion. , 2003, Physiological reviews.

[99]  J. Lilien,et al.  Essential Tyrosine Residues for Interaction of the Non-receptor Protein-tyrosine Phosphatase PTP1B with N-cadherin* , 2001, Journal of Biological Chemistry.

[100]  E. Fischer,et al.  COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus , 1995, The Journal of cell biology.

[101]  M. Tremblay,et al.  Murine embryonic fibroblasts lacking TC-PTP display delayed G1 phase through defective NF-κB activation , 2001, Oncogene.

[102]  B. Neel,et al.  Neuronal PTP1B regulates body weight, adiposity and leptin action , 2006, Nature Medicine.

[103]  R. Bast,et al.  Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas. , 1994, American journal of obstetrics and gynecology.

[104]  Veena Sangwan,et al.  Protein-tyrosine Phosphatase 1B Deficiency Protects against Fas-induced Hepatic Failure* , 2006, Journal of Biological Chemistry.

[105]  D. Barford,et al.  TYK2 and JAK2 Are Substrates of Protein-tyrosine Phosphatase 1B* , 2001, The Journal of Biological Chemistry.

[106]  Thomas S. Lin,et al.  STAT signaling in the pathogenesis and treatment of leukemias , 2000, Oncogene.

[107]  B. Kennedy,et al.  Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis , 2007, Nature Genetics.

[108]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[109]  M. Tremblay,et al.  T-Cell Protein Tyrosine Phosphatase (Tcptp) Is a Negative Regulator of Colony-Stimulating Factor 1 Signaling and Macrophage Differentiation , 2006, Molecular and Cellular Biology.

[110]  N. Tonks,et al.  Regulation of Insulin Signaling through Reversible Oxidation of the Protein-tyrosine Phosphatases TC45 and PTP1B* , 2004, Journal of Biological Chemistry.

[111]  M. Karin.  Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.

[112]  Michael Karin,et al.  NF-kappaB: linking inflammation and immunity to cancer development and progression. , 2005, Nature reviews. Immunology.

[113]  B. Neel,et al.  The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence , 1992, Cell.

[114]  A. Schmid,et al.  Direct interaction between ER membrane-bound PTP1B and its plasma membrane-anchored targets. , 2007, Cellular signalling.

[115]  R. DePinho,et al.  Malignant glioma: genetics and biology of a grave matter. , 2001, Genes & development.

[116]  D. Hill,et al.  Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene. , 1992, Cancer research.

[117]  T. Hunter,et al.  Oncogenic kinase signalling , 2001, Nature.

[118]  David E Levy,et al.  STAT1 acts as a tumor promoter for leukemia development. , 2006, Cancer cell.

[119]  F. Haj,et al.  PTP-1B is an essential positive regulator of platelet integrin signaling , 2005, The Journal of cell biology.

[120]  M. Aurrand-Lions,et al.  Dual role of macrophages in tumor growth and angiogenesis , 2006, Journal of leukocyte biology.

[121]  M. Tremblay,et al.  The Catalytic Activity of the Eukaryotic Initiation Factor-2α Kinase PKR Is Required to Negatively Regulate Stat1 and Stat3 via Activation of the T-cell Protein-tyrosine Phosphatase* , 2006, Journal of Biological Chemistry.

[122]  R. Jain,et al.  The role of nitric oxide in tumour progression , 2006, Nature Reviews Cancer.

[123]  A. Schmid,et al.  Characterization of the C-terminal ER membrane anchor of PTP1B. , 2007, Experimental cell research.

[124]  T. Wang,et al.  Inflammation, atrophy, and gastric cancer. , 2007, The Journal of clinical investigation.

[125]  Asim Khwaja,et al.  The role of Janus kinases in haemopoiesis and haematological malignancy , 2006, British journal of haematology.

[126]  L. Wennogle,et al.  The Role of the C-terminal Domain of Protein Tyrosine Phosphatase-1B in Phosphatase Activity and Substrate Binding* , 2007, Journal of Biological Chemistry.

[127]  Hsien-yu Wang,et al.  Insulin Stimulates Tyrosine Phosphorylation and Inactivation of Protein-tyrosine Phosphatase 1B in Vivo * , 2001, The Journal of Biological Chemistry.

[128]  M. Tremblay,et al.  Cloning and characterization of a mouse cDNA encoding a cytoplasmic protein-tyrosine-phosphatase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[129]  J. Lilien,et al.  Continuous association of cadherin with β-catenin requires the non-receptor tyrosine-kinase Fer , 2004, Journal of Cell Science.

[130]  N. Tonks,et al.  The Reciprocal Role of Egr-1 and Sp Family Proteins in Regulation of the PTP1B Promoter in Response to the p210 Bcr-Abl Oncoprotein-tyrosine Kinase* , 2001, The Journal of Biological Chemistry.

[131]  Manuela Klingler-Hoffmann,et al.  The T-cell protein tyrosine phosphatase is phosphorylated on Ser-304 by cyclin-dependent protein kinases in mitosis. , 2004, The Biochemical journal.

[132]  I. Lossos,et al.  T-Cell Protein Tyrosine Phosphatase, Distinctively Expressed in Activated-B-Cell-Like Diffuse Large B-Cell Lymphomas, Is the Nuclear Phosphatase of STAT6 , 2007, Molecular and Cellular Biology.

[133]  J. Pollard,et al.  Macrophages regulate the angiogenic switch in a mouse model of breast cancer. , 2006, Cancer research.

[134]  M. Quon,et al.  Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor. , 2001, Molecular endocrinology.

[135]  G. Hannon,et al.  Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[136]  G. Lesinski,et al.  The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse , 2003 .

[137]  R. Bast,et al.  Expression of cell regulatory proteins in ovarian borderline tumors , 1996, Cancer.

[138]  M. Tremblay,et al.  Regulation of Insulin-Like Growth Factor Type I (IGF-I) Receptor Kinase Activity by Protein Tyrosine Phosphatase 1B (PTP-1B) and Enhanced IGF-I-Mediated Suppression of Apoptosis and Motility in PTP-1B-Deficient Fibroblasts , 2002, Molecular and Cellular Biology.

[139]  T. Mustelin,et al.  Arginine Methylation of STAT1 Regulates Its Dephosphorylation by T Cell Protein Tyrosine Phosphatase* , 2002, The Journal of Biological Chemistry.

[140]  E. Yorida,et al.  HER-2 Suppression of the Epidermal Growth Factor Receptor and Disruption of the Y-Box Binding Protein-1 Results in Updated , 2006 .

[141]  Joanna M. Sasin,et al.  Protein Tyrosine Phosphatases in the Human Genome , 2004, Cell.

[142]  G. Lesinski,et al.  The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. , 2003, The Journal of clinical investigation.

[143]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[144]  E. Krebs,et al.  cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[145]  M. Tremblay,et al.  Nuclear localization and cell cycle regulation of a murine protein tyrosine phosphatase , 1994, Molecular and cellular biology.

[146]  Heung-Chin Cheng,et al.  Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530 , 1999, Oncogene.